Gopinath Ranganna

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Metabolic Syndrome

Top Venues

Diabetes, obesity & metabolism

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas C Blevins, Yaron Raiter, Bin Sun, Charles Donnelly, Roxann Shapiro, Anoop Chullikana, Anita Rao, Laxmikant Vashishta, Gopinath Ranganna, Abhijit Barve
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog ® ) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (6) (2022)
Ulrike Hoevelmann, Yaron Raiter, Anoop Chullikana, Mark Liu, Charles Donnelly, Tracey Lawrence, Nilanjan Sengupta, Gopu Cl, Gopinath Ranganna, Abhijit Barve
Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar MYL-1601D with US and European insulin aspart in healthy volunteers: A randomized, double-blind, crossover, euglycaemic glucose clamp study. Diabetes, obesity & metabolism 23 (12) (2021)